[go: up one dir, main page]

PT969877E - Metodos para a modulacao do crescimento de arterias colaterais e/ ou de outras arterias a partir de ligacoes arteriolares pre-existentes - Google Patents

Metodos para a modulacao do crescimento de arterias colaterais e/ ou de outras arterias a partir de ligacoes arteriolares pre-existentes

Info

Publication number
PT969877E
PT969877E PT98924093T PT98924093T PT969877E PT 969877 E PT969877 E PT 969877E PT 98924093 T PT98924093 T PT 98924093T PT 98924093 T PT98924093 T PT 98924093T PT 969877 E PT969877 E PT 969877E
Authority
PT
Portugal
Prior art keywords
arteries
growth
methods
collateral
mcp
Prior art date
Application number
PT98924093T
Other languages
English (en)
Inventor
Wolfgang Schaper
Wulf D Ito
Original Assignee
Max Planck Ges Zur Forderung W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Ges Zur Forderung W filed Critical Max Planck Ges Zur Forderung W
Publication of PT969877E publication Critical patent/PT969877E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/195—Chemokines, e.g. RANTES
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Liquid Crystal Display Device Control (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT98924093T 1997-04-04 1998-04-01 Metodos para a modulacao do crescimento de arterias colaterais e/ ou de outras arterias a partir de ligacoes arteriolares pre-existentes PT969877E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97105647 1997-04-04

Publications (1)

Publication Number Publication Date
PT969877E true PT969877E (pt) 2003-06-30

Family

ID=8226664

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98924093T PT969877E (pt) 1997-04-04 1998-04-01 Metodos para a modulacao do crescimento de arterias colaterais e/ ou de outras arterias a partir de ligacoes arteriolares pre-existentes

Country Status (10)

Country Link
US (2) US6592862B1 (pt)
EP (2) EP0969877B1 (pt)
JP (1) JP2001519795A (pt)
AT (1) ATE232399T1 (pt)
CA (1) CA2284922A1 (pt)
DE (1) DE69811348T2 (pt)
DK (1) DK0969877T3 (pt)
ES (1) ES2187972T3 (pt)
PT (1) PT969877E (pt)
WO (1) WO1998044953A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528625B1 (en) 1996-10-28 2003-03-04 Millennium Pharmaceuticals, Inc. Anti-CCR5 antibodies and kits comprising same
ES2221212T5 (es) 1997-10-02 2008-12-01 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Metodos para la modulacion de la neovascularizacion y/o el crecimiento de arterias colaterales y/o de otras arterias a partir de conexiones arteriolares preexistentes.
US6749617B1 (en) 1997-11-04 2004-06-15 Scimed Life Systems, Inc. Catheter and implants for the delivery of therapeutic agents to tissues
US6312689B1 (en) 1998-07-23 2001-11-06 Millennium Pharmaceuticals, Inc. Anti-CCR2 antibodies and methods of use therefor
US6727349B1 (en) 1998-07-23 2004-04-27 Millennium Pharmaceuticals, Inc. Recombinant anti-CCR2 antibodies and methods of use therefor
US6696550B2 (en) 1998-07-23 2004-02-24 Millennium Pharmaceuticals, Inc. Humanized anti-CCR2 antibodies and methods of use therefor
US6245332B1 (en) 1999-01-15 2001-06-12 The Board Of Trustees Of The Leland Stanford Junior University Modulation of systemic memory T cell trafficking
US6488930B1 (en) 1999-01-15 2002-12-03 Millennium Pharmaceuticals, Inc. Anti-CCR4 antibodies and methods of use therefor
US6329510B1 (en) 1999-01-29 2001-12-11 Millennium Pharmaceuticals, Inc. Anti-CCR1 antibodies and methods of use therefor
AU4544600A (en) * 1999-04-06 2000-10-23 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Pharmaceutical compositions comprising circulating blood cells, preferably monocytes and uses thereof
AU2001261737A1 (en) * 2000-05-18 2001-11-26 Genetix Pharmaceuticals, Inc. Methods and compositions for promoting angiogenesis using monocytes
AU6174301A (en) * 2000-05-19 2001-12-03 Us Health Methods for reducing tumor growth and metastasis by inhibiting mcp-1 activity
EP1383551B1 (en) * 2000-11-08 2010-07-14 Boston Scientific Limited Multilumen catheter and implants for the delivery of therapeutic agents to tissues
DK1409506T3 (da) 2001-07-23 2012-08-06 Univ Leland Stanford Junior Fremgangsmåder og sammensætninger til RNAi-formidlet inhibering af genekspression i pattedyr
US10590418B2 (en) 2001-07-23 2020-03-17 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for RNAi mediated inhibition of gene expression in mammals
US20040151721A1 (en) 2001-10-19 2004-08-05 O'keefe Theresa Humanized anti-CCR2 antibodies and methods of use therefor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5179078A (en) * 1989-05-12 1993-01-12 Dana Farber Cancer Institute Method of suppressing tumor formation in vivo
NZ266979A (en) * 1994-05-16 1999-01-28 Human Genome Sciences Inc Monocyte chemotactic protein-4 (mcp-4)and related fragments, vectors, antibodies, host cells, compositions and (ant)agonists
US6100242A (en) * 1995-02-28 2000-08-08 The Regents Of The University Of California Gene therapies for enhancing cardiac function
US6544543B1 (en) * 2000-12-27 2003-04-08 Advanced Cardiovascular Systems, Inc. Periodic constriction of vessels to treat ischemic tissue

Also Published As

Publication number Publication date
EP1304123A2 (en) 2003-04-23
EP1304123A3 (en) 2003-11-19
DK0969877T3 (da) 2003-03-24
CA2284922A1 (en) 1998-10-15
US20040023881A1 (en) 2004-02-05
US6592862B1 (en) 2003-07-15
ES2187972T3 (es) 2003-06-16
EP0969877B1 (en) 2003-02-12
DE69811348T2 (de) 2003-12-24
ATE232399T1 (de) 2003-02-15
WO1998044953A1 (en) 1998-10-15
JP2001519795A (ja) 2001-10-23
DE69811348D1 (de) 2003-03-20
EP0969877A1 (en) 2000-01-12

Similar Documents

Publication Publication Date Title
PT969877E (pt) Metodos para a modulacao do crescimento de arterias colaterais e/ ou de outras arterias a partir de ligacoes arteriolares pre-existentes
DK1019082T4 (da) Fremgangsmåde til moduleringen af neovaskularisering og/eller væksten af kollaterale arterier og/eller andre arterier fra forudeksisterende arteriolære forbindelser
BR0211546A (pt) Composição farmacêutica e/ou de diagnóstico e uso de microrganismo ou célula
EA200000445A1 (ru) Способы лечения состояния гиперкоагуляции или приобретенной недостаточности белка c
PT1157041E (pt) Anticorpos para terapia e diagnostico de cancro
DE69532760D1 (de) Mittel zur verabreichung von antigenen
ATE375362T1 (de) Von cyclophilin b abstammende tumorantigen- peptide
ATE516304T1 (de) Nrg-2 nukleinsäuren, polypeptide und diagnostische / therapeutische methoden
ATE342359T1 (de) Design von beta-faltblatt-proteinen mit spezifischen bindungseigenschaften
EA199801044A1 (ru) Модуляторы регенерации тканей
DK1132097T3 (da) Celle- og serumproteinankere og -konjugater
ES2178854T3 (es) Bibliotecas de marcadores de afinidad para albumina de suero humano.
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
BR9811094A (pt) Agente terapêutico para tumores linfáticos
SE8902532L (sv) Bestaemning av plasmaproteiner
NO971341D0 (no) Promoter for reseptor tyrosinkinase TIE
ES2141249T3 (es) Procedimiento para la identificacion de celulas humanas y animales que presentan la capacidad para una proliferacion ilimitada o para una formacion de tumores.
ATE384263T1 (de) Verfahren zur bestimmung von biologischen agenzien in lebenden zielzellen
DE69728897D1 (de) Saeugetierchemokine
ID29405A (id) Protein antigen tumor sart-3 yang baru dan peptida-peptida antigen tumornya
DE69636041D1 (de) Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen
DE59709856D1 (de) Konjugat aus albumin und einem xanthen-farbstoff zur unterscheidung von krankhaftem und gesundem gewebe
ITRM920506A1 (it) Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.
DE69929683D1 (de) Antisense modulierung von lfa-3
ATE320818T1 (de) Mittel zur identifizierung und therapie metastasierender tumore